KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Operating Margin (2018 - 2025)

Historic Operating Margin for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to 10.95%.

  • Adaptive Biotechnologies' Operating Margin rose 812200.0% to 10.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.93%, marking a year-over-year increase of 817600.0%. This contributed to the annual value of 90.83% for FY2024, which is 425000.0% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Operating Margin is 10.95%, which was up 812200.0% from 42.52% recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Operating Margin ranged from a high of 10.95% in Q3 2025 and a low of 621.01% during Q2 2023
  • For the 5-year period, Adaptive Biotechnologies' Operating Margin averaged around 132.07%, with its median value being 116.45% (2024).
  • Per our database at Business Quant, Adaptive Biotechnologies' Operating Margin plummeted by -5007600bps in 2023 and then skyrocketed by 5114600bps in 2024.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Operating Margin stood at 162.39% in 2021, then skyrocketed by 56bps to 70.99% in 2022, then plummeted by -119bps to 155.22% in 2023, then soared by 54bps to 71.3% in 2024, then skyrocketed by 115bps to 10.95% in 2025.
  • Its Operating Margin was 10.95% in Q3 2025, compared to 42.52% in Q2 2025 and 56.45% in Q1 2025.